Glyphosate’s role in renal tubular injury at low exposure levels: evidence from a patient cohort Authors: Gang Zhou, Mingzhu Jiang, Yi Zhang, Bo Gao, Daoliang Xu, Ying Cui Published: 2026 ABSTRACT AbstractGlyphosate (GLY), a widely used herbicide, poses potential health risks even at low exposure levels and is prevalent in the general population through dietary and environmental residues. GLY accumulation may contribute to renal injury, but population-based evidence remains limited. We retrospectively studied 110 non-occupationally exposed patients undergoing renal biopsy,classified into two groups based on tubular injury score: mild (score 1, n = 69) and moderate-to-severe injury (score 2–4, n = 41). Median urinary GLY concentration was 2.50 ng/ml (IQR 1.40–3.12), higher in the moderate-to-severe group. Urinary GLY levels were positively correlated with tubular injury score. After full adjustment in multivariable logistic regression, individuals in the third quartile of urinary GLY (2.50–3.12 ng/ml) had a 26.30-fold higher risk of moderate-to-severe tubular injury compared with the lowest quartile (p = 0.008). Restricted cubic spline (RCS) analysis confirmed a significant nonlinear association between urinary GLY and moderate-to-severe injury. Urinary GLY demonstrated good predictive performance for moderate-to-severe tubular injury (AUC = 0.707). Literature review and network toxicology analysis suggested that GLY may induce cytotoxicity and genetic damage, contributing to renal injury in humans. These findings support the potential nephrotoxic effects of low-dose glyphosate exposure in a clinical cohort and add to the limited epidemiological evidence linking environmental exposure to renal pathological injury. Introduction Glyphosate (GLY), a widely used herbicide globally, has been detected in soil, crop products, animals fed with crops, humans, freshwater, and organisms inhabiting these environments [1]. China is a major agricultural country, with GLY concentrations in groundwater reaching levels as high as 5.13 μg/L [2]. GLY can be absorbed through oral, dermal, conjunctival, gastrointestinal, and respiratory pathways [3]. An increasing number of studies have indicated that even at low-level exposure, GLY may cause adverse health effects, including cancer, abnormal blood pressure, metabolic syndrome, liver damage, and respiratory and renal dysfunction [1,2,4–6]. Urinary excretion is one of the main elimination pathways of GLY in humans [7]. It was shown that long-term exposure to GLY and its metabolite AMPA may lead to chronic kidney injury through apoptosis of renal tubular cells [8,9]. The association between urinary GLY levels and renal damage in children living near vegetable-cultivating regions was evaluated in Shandong Province, China [10]. In this population, GLY was detected in 92.05% of urine samples and was associated with kidney injury biomarkers, including neutrophil gelatinase-associated lipid carrier protein (NGAL) and kidney injury molecule 1 (KIM-1) [10]. Another study showed that exposure to low-dose GLY (0.5 mg/kg) from weaning to adulthood in male Wistar rats induced mild kidney damage, primarily evidenced by increased expression of the KIM-1 biomarker and associated tubular morphological changes [11]. Nevertheless, the association between environmental GLY exposure and renal tubular histopathology remains uncertain. This study examined the association between urinary GLY levels and renal tubular injury based on renal histopathological findings in non-occupationally exposed patients with kidney disease. Materials and methods Study population This observational study randomly enrolled 110 patients who underwent renal biopsy at the Department of Nephrology, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, between February and October 2022. Demographic information, including age, sex, occupation, habitation, and comorbidities was recorded. Patients were excluded if they were under 18 years of age, or had a history of GLY occupational exposure (defined as employment in herbicide industrial production, farming, or other high‑risk occupational settings). Clinical characteristics Clinical and laboratory data at the time of renal biopsy were extracted from existing medical records, including serum uric acid, urea, creatinine (Cr), 24-h urinary protein excretion, urinary N-acetyl-D-glucosaminidase (NAG), and serum and urinary β2-microglobulin (β2-MG). The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula [12]. Assessment of urine GLY concentration Midstream first-voided morning urine samples were collected on the day of renal biopsy, which was performed on the second morning after hospital admission. Urine samples were immediately aliquoted and frozen at the collection site. The samples were processed on dry ice and transported to Yangzhou Center for Disease Control and Prevention. All samples were stored at −18 °C until analysis. Urinary GLY concentrations were determined using derivatization gas chromatography-mass spectrometry (GC-MS), as previously described [13]. According to Li W’s data processing method [5], analyte concentrations below the detection limit (2 ng/ml) were replaced with the detection limit divided by the square root of 2 (detection rate: 74.55%). Renal pathology scoring and grouping As per routine clinical practice, kidney biopsy specimens were independently evaluated by two experienced pathologists who were blinded to patients’ urinary glyphosate levels and all clinical data. Tubular injury scores were calculated by quantifying specific histopathological alterations, including tubular atrophy, vacuolar degeneration of tubular epithelial cells, loss of the brush border, tubular dilation, and tubulitis. A similar semi-quantitative method was used to score interstitial fibrosis, renal interstitial edema, and inflammatory cell infiltration. Referring to the Banff working classification criteria [14,15], injury severity was assessed using a scoring system from 1 to 4 as follows: score 1, ≤25% injury; score 2, 26%-50% injury; score 3, 51%-75% injury; score 4, >75% injury. The percentages represent the proportion of renal parenchyma affected by the lesion. Interobserver agreement was not formally assessed, as scoring was performed as part of routine clinical practice using standardized criteria. Based on the tubular injury score, enrolled patients were divided into two groups: mild tubular injury (score 1, n = 69) and moderate-to-severe tubular injury (score 2–4, n = 41). Network toxicology analysis GLY-related targets were identified using two authoritative databases, GeneCards (the GeneCards Human Gene Database) and STITCH (Search Tool for Interacting Chemicals, http://stitch-db.org/). The identified potential targets were further subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses using the online platform Hiplot [16] and the OMICSTUDIO tool [17]. The interaction network between GLY and its potential targets was constructed by using Cytoscape 3.10.4 [18]. Statistical analyses Statistical analyses were performed using SPSS (version 24.0, SPSS Inc., USA) and RStudio (version 4.4.0). Data were presented as mean ± standard deviation (SD) for normally distributed continuous variables, median (interquartile range, IQR) for skewed continuous variables, and frequencies (percentages) for categorical variables. Continuous variables were compared between groups using Student’s t-test or the Mann-Whitney U-test, as appropriate. The chi-square test was used for categorical variables. Spearman correlation analyses were performed to examine the relationships between tubular injury score and renal damage markers, including serum β2-MG, urinary β2-MG, NAG, and GLY levels. In addition, associations between urinary GLY and these renal damage markers were analyzed and presented in a heat map. To evaluate the association between urinary GLY and moderate-to-severe renal tubular injury, three logistic regression models were constructed: unadjusted, adjusted for significant indicators, and fully adjusted for all covariates. Urinary GLY levels were categorized into four quartiles, with the first quartile used as the reference group. Restricted cubic spline (RCS) logistic regression using the ‘rms’ R package was applied to explore potential nonlinear relationships between urinary GLY levels and tubular injury severity. In addition, receiver operating characteristic (ROC) curve analysis was performed to calculate the area under the curve (AUC) and assess the diagnostic value of urinary GLY levels for moderate-to-severe tubular injury. A two-sided P-value <0.05 was considered statistically significant. Results Demographic and clinical characteristics of the study population As shown in Table 1, the study included 110 patients with a mean age of 47.36 years; 46.36% were men and 53.64% were women. Of the study population, 54.5% were rural residents and 45.5% were urban residents, with no statistically significant difference between the two groups. Primary glomerular diseases were the main pathological diagnoses (78.18%). No significant difference was observed in the distribution of pathological diagnoses between the two groups. Compared with patients with mild tubular injury, those with moderate-to-severe tubular injury were older and had higher blood pressure (BP), serum uric acid, urea, and Cr levels. The eGFR in patients with moderate-to-severe tubular injury was 57.29 ± 28.88 mL/min/(1.73 m2), which was significantly lower than that in patients with mild tubular injury (p < 0.001). No significant difference was observed in 24-h urinary protein between the two groups (p = 0.05). Table 1.Baseline characteristics of the patients stratified by tubular injury score (N = 110).VariablesTotal (n = 110)Mild tubular injurya (n = 69)Moderate-to-severe tubular injurya (n = 41)P value Demographics Sex: men, n (%)51 (46.36)30 (43.48)21 (51.22)0.431Residence: rural/ urban, n (%)60 (54.50)/ 50 (44.50)37 (53.60)/ 32 (46.40)23 (56.10)/ 18 (43.90)0.340Age (years)47.36 ± 15.4244.06 ± 15.1952.93 ± 14.320.003BMI (kg/m2)24.37 ± 3.7624.27 ± 3.9524.54 ± 3.460.721Systolic BP (mmHg)133.06 ± 14.01129.93 ± 12.12138.34 ± 15.480.002Diastolic BP (mmHg)82.35 ± 11.6780.33 ± 10.1085.73 ± 13.390.018 Comorbidities, n (%) Hypertension59 (53.64)31 (44.93)28 (68.29)0.017Diabetic mellitus17 (15.45)8 (11.59)9 (21.95)0.146 Pathologic diagnoses, n (%) 0.164Primary glomerular diseases86 (78.18)55 (79.71)31 (75.61) Diabetic nephropathy3 (2.73)0 (0.00)3 (7.32) Hypertensive nephropathy2 (1.82)2 (2.90)0 (0.00) Tubulointerstitial disease2 (1.82)1 (1.45)1 (2.44) Othersb17 (15.45)11 (15.94)6 (14.63) Laboratory values Hemoglobin (g/L)128.18 ± 25.35132.43 ± 25.26121.02 ± 24.130.022Alb (g/L)35.03 ± 9.1435.92 ± 9.3833.52 ± 8.630.184Glucose (mmol/L)5.09 ± 1.185.09 ± 1.255.10 ± 1.080.963Cr (μmol/L)85.00 (62.00–123.75)75.00 (59.00 – 101.50)117.00 (82.00 – 171.50)<0.001eGFR [mL/min/(1.73 m2)]77.63 ± 31.7989.72 ± 27.0557.29 ± 28.88<0.001Serum β2-MG (μg/ml)2.15 (1.75 – 3.33)2.01 (1.64 – 2.57)2.62 (2.07 – 4.17)<0.001Urine PH6.00 (5.50 – 7.00)6.00 (5.50 – 7.00)5.50 (5.50 – 6.50)0.013Urinary density1.02 (1.01 – 1.02)1.02 (1.01 – 1.03)1.02 (1.01 – 1.02)0.04824-hour urinary protein (g)1.41 (0.55 – 3.66)1.10 (0.46 – 3.08)1.87 (0.89 – 3.97)0.050Urinary β2-MG (μg/ml)0.42 (0.25 – 0.68)0.44 (0.27 – 0.59)0.39 (0.19 – 0.98)0.779Urinary NAG (U/L)20.30 (12.15 – 34.33)19.50 (12.70 – 33.40)23.70 (11.60 – 38.70)0.582Urinary GLY (ng/ml)2.50 (1.40 – 3.12)2.33 (1.40 – 2.92)2.96 (2.37 – 3.32)<0.001Urinary β2-MG/ urinary density0.39 (0.23 – 0.62)0.42 (0.26 – 0.57)0.34 (0.18 – 0.91)0.456Urinary NAG/ urinary density19.28 (11.61 – 32.59)18.44 (11.76 – 30.83)20.53 (10.53 – 35.54)0.729Urinary GLY/ urinary density2.47 (1.41 – 3.04)2.26 (1.39 – 2.84)2.93 (2.34 – 3.26)<0.001 a Patients with mild tubular injury: tubular injury score 1 (≤25% injury); moderate-to-severe tubular injury: tubular injury score 2–4 (>25% injury). b Other pathologic diagnoses include lupus nephritis, obesity-related glomerulopathy, Henoch-Schonlein purpura nephritis and ANCA-associated vasculitis.Data are presented as mean ± SD, numbers and percentages, or median (25th-75th percentile), as appropriate. Abbreviations: BMI, body mass index; BP, blood pressure; TP, total protein; Alb, albumin; Cr, creatinine; eGFR, estimated glomerular filtration rate; β2-MG, β2-microglobulin; NAG, N-acetyl-D-glucosaminidase; GLY, glyphosate. Baseline characteristics of the patients stratified by tubular injury score (N = 110). Patients with mild tubular injury: tubular injury score 1 (≤25% injury); moderate-to-severe tubular injury: tubular injury score 2–4 (>25% injury). Other pathologic diagnoses include lupus nephritis, obesity-related glomerulopathy, Henoch-Schonlein purpura nephritis and ANCA-associated vasculitis. Data are presented as mean ± SD, numbers and percentages, or median (25th-75th percentile), as appropriate. Abbreviations: BMI, body mass index; BP, blood pressure; TP, total protein; Alb, albumin; Cr, creatinine; eGFR, estimated glomerular filtration rate; β2-MG, β2-microglobulin; NAG, N-acetyl-D-glucosaminidase; GLY, glyphosate. Serum β2-MG levels were higher in patients with moderate-to-severe tubular injury than in those with mild injury, whereas urinary β2-MG and NAG levels showed no significant difference (Table 1). Median urinary GLY concentration was 2.50 ng/ml (IQR 1.40 to 3.12), with a significant difference between the mild and moderate-to-severe tubular injury groups [2.33 (1.40– 2.92) ng/ml vs. 2.96 (2.37– 3.32) ng/ml, p < 0.001; Table 1]. Furthermore, after normalization for urinary density, urinary GLY concentrations continued to show a significant difference between the two groups. Associations between urinary GLY and renal tubular injury The Spearman’s correlation coefficients were used to investigate the relationships between renal biomarkers and histopathological parameters. Regarding tubular injury, serum β2-MG and urinary GLY levels showed positive associations with tubular injury score, with correlation coefficients of 0.430 and 0.297, respectively (p < 0.01). In contrast, no significant correlations were observed for urinary β2-MG and NAG levels. Furthermore, associations between urinary GLY and other renal histopathological features, including renal interstitial edema, inflammatory cell infiltration, and interstitial fibrosis were evaluated; however, none of these correlations reached statistical significance (all p > 0.05), suggesting that the observed GLY- associated histopathological effects in this cohort were relatively specific to tubular injury. We further examined the association between urinary GLY quartiles and moderate-to-severe tubular injury using multivariable-adjusted binary logistic regression models (Table 2). Across all models, elevated urinary GLY levels were consistently associated with an increased risk of moderate-to-severe tubular injury. In the fully adjusted model, individuals in the third quartile of urinary GLY (Q3) showed a 26.30-fold increased risk of moderate-to-severe tubular injury compared with those in the lowest quartile (Q1) (OR: 26.296, 95% CI: 2.311–299.183; p = 0.008). Table 2.Multiple logistic regression of the relationship between urinary GLY concentrations and moderate-to-severe tubular injury.ExposureModel 1Model 2Model 3OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueUrinary GLY Q1Reference Reference Reference Q24.167 (0.987, 17.591)0.0523.581 (0.607, 21.119)0.1595.681 (0.684, 47.198)0.108Q37.222 (1.765, 29.557)0.00615.162 (2.080, 110.510)0.00726.296 (2.311, 299.183)0.008Q412.121 (2.923, 50.272)0.00110.349 (1.654, 64.755)0.01233.644 (2.931, 386.146)0.005Note: The quartiles are categorized into Q1(≤1.4 ng/ml), Q2(1.4–2.50 ng/ml), Q3(2.50–3.12 ng/ml) and Q4(>3.12 ng/ml) based on urinary GLY levels.Model 1: No covariates are adjusted.Model 2: Hypertension, age, circulating Hb, serum β2-MG, eGFR, urine PH, urinary density and 24-h urinary protein are adjusted.Model 3: Based on Model 2, additionally diabetic mellitus, sex, residence, BMI, serum Alb levels, urinary β2-MG and NAG levels are adjusted.Abbreviations: GLY, glyphosate; OR, odds ratio; CI, confidence interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Hb, hemoglobin; β2-MG, β2-microglobulin; eGFR, estimated glomerular filtration rate; Alb, albumin; NAG, N-acetyl-D-glucosaminidase. Multiple logistic regression of the relationship between urinary GLY concentrations and moderate-to-severe tubular injury. Note: The quartiles are categorized into Q1(≤1.4 ng/ml), Q2(1.4–2.50 ng/ml), Q3(2.50–3.12 ng/ml) and Q4(>3.12 ng/ml) based on urinary GLY levels. Model 1: No covariates are adjusted. Model 2: Hypertension, age, circulating Hb, serum β2-MG, eGFR, urine PH, urinary density and 24-h urinary protein are adjusted. Model 3: Based on Model 2, additionally diabetic mellitus, sex, residence, BMI, serum Alb levels, urinary β2-MG and NAG levels are adjusted. Abbreviations: GLY, glyphosate; OR, odds ratio; CI, confidence interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Hb, hemoglobin; β2-MG, β2-microglobulin; eGFR, estimated glomerular filtration rate; Alb, albumin; NAG, N-acetyl-D-glucosaminidase. In addition, RCS analysis revealed a statistically significant nonlinear relationship between urinary GLY concentrations and moderate-to-severe tubular injury (P for nonlinearity = 0.008) (shown in Figure 1). Threshold effect analysis identified an inflection point at 2.50. When urinary GLY levels exceeded this inflection point, the risk of moderate-to-severe tubular injury increased rapidly. The restricted cubic spline for the association between urinary GLY concentrations and moderate-to-severe tubular injury. The fitted regression line is a solid blue line; the shaded area indicates the 95% CI; the black dashed line indicates the position where the OR is equal to 1. Abbreviations: RCS, restricted cubic spline; GLY, glyphosate; OR, odds ratio; CI, confidence interval. Diagnostic value of urinary GLY levels for renal tubular injury ROC curves were plotted to assess the diagnostic value of urinary GLY for moderate-to-severe tubular injury. As presented in Figure 2, urinary GLY levels demonstrated moderate predictive performance (AUC = 0.707, 95% CI 0.610–0.805), with an optimal cutoff value of 2.70 ng/ml, yielding 65.9% sensitivity and 69.6% specificity. The ROC curve of urinary GLY for the diagnosis of moderate-to-severe tubular injury. Correlations among various serum and urinary renal injury biomarkers Furthermore, correlations among serum and urinary renal injury biomarkers were assessed using Spearman’s correlation coefficients and visualized in Figure 3. None of the evaluated biomarkers, including serum Cr, serum and urinary β2-MG, urinary NAG, 24-h urinary protein, and eGFR, showed significant correlations with urinary GLY levels. Correlations between serum and urinary renal injury biomarkers. Blue represents positive correlations, and red represents negative correlations. The sizes of the circles are plotted in proportion to the value of correlations. *P < 0.05; **P < 0.01. Abbreviations: GLY, glyphosate; β2-MG, β2-microglobulin; NAG, N-acetyl-D-glucosaminidase; Cr, creatinine; eGFR, estimated glomerular filtration rate. The potential target for GLY resulting in renal tubular injury Seventy-two GLY-related targets were identified from GeneCards and STITCH, while 6717 genes related to renal tubular injury were retrieved from GeneCards. Venn diagram intersection analysis identified 59 overlapping targets as potential key targets (shown in Figure 4A-B). KEGG and GO enrichment analyses were subsequently performed. GO analysis includes biological process (BP), cellular component (CC), and molecular function (MF) (Figure 4C). The enriched BPs were significantly associated with ‘response to xenobiotic stimulus’, ‘female gonad development’, ‘xenobiotic catabolic process’, and others. In terms of CCs, the targets were prominently enriched in components related to the ‘mitochondrial outer membrane’ and ‘transcription regulator complex’. The MF analysis indicated that the genes were mainly involved in oxidoreductase activity and monooxygenase activity. (A) The Venn diagram between GLY targets and renal tubular injury. (B) The network between GLY and shared targets. (C) GO analysis for shared targets. (D) KEGG analysis for shared targets. Abbreviations: GLY, glyphosate; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes. Furthermore, KEGG pathway analysis of the 59 putative targets identified multiple enriched pathways potentially involved in GLY-related effects, including apoptosis, the p53 signaling pathway, and other cancer-associated pathways (Figure 4D). Discussion Due to the widespread use of GLY or GLY-based herbicides (GBH), increasing attention has been paid to its bioaccumulation and associated adverse health outcomes in the general population. A key feature of GLY toxicokinetic is its urinary excretion, with a positive correlation between exposure and urinary levels, making it a useful biomarker for biomonitoring [19,20]. Gillezeau et al. reviewed studies on human GLY concentrations and found that occupational exposure resulted in urinary levels ranging from 0.26 to 73.5 μg/L, while levels in the general population ranged from 0.16 to 7.6 μg/L [21]. A systematic review reported that urinary GLY concentrations in non-occupationally exposed populations ranged from 0.20 ng/mL to 7.19 ng/mL [22], and a large French population-based study (n = 6,848) reported a mean concentration of 1.19 ng/mL with a 99.8% detection rate [23]. The median urinary GLY concentration in our cohort (2.50 ng/mL) is comparable to levels reported in large-scale biomonitoring studies of the general population. These findings indicate that low-level GLY exposure is widespread in the general population through dietary and environmental pathways. It is well established that occupational GLY exposure is associated with renal dysfunction, and chronic kidney disease (CKD) [11,20,24]. Increasing evidence suggests that even low-level exposure to GLY may also exert harmful effects [1,11]. A cross-sectional analysis of NHANES data from 2013 to 2014 in adults showed a positive association between urinary GLY and albumin-to-creatinine ratio (ACR), and higher urinary GLY levels were negatively associated with eGFR [1]. In urban areas, where GLY exposure is typically expected to be lower, over 90% of the pediatric population was found to have detectable urinary GLY concentrations [25]. Multiple linear regression analysis further indicated that GLY exposure was the only significant factor associated with KIM-1 concentrations, with a 42% increase in KIM-1 per unit increase in GLY exposure [25]. These findings highlight that not only occupationally exposed individuals such as farmers, but the general population as well, should be aware of potential renal risks associated with widespread GLY contamination. Previous studies have demonstrated that GLY exhibits both cytotoxic and genotoxic effects on the kidney (Table 3). Wistar rats administered long-term low doses of GLY-based herbicides orally exhibited necrobiotic changes in tubular epithelial cells, along with tubulointerstitial edema and mononuclear cell infiltration [11,26]. Similarly, Liu et al. observed that GLY-induced kidney damage in poultry was characterized by tubular rupture, luminal content leakage, and cellular swelling [27]. In addition, case reports have indicated that acute GBH poisoning can lead to acute tubulointerstitial nephritis or acute tubular necrosis [28,29]. Nevertheless, population-based studies investigating the impact of GLY exposure on renal pathological changes remain limited. To our knowledge, our study is the first to identify an association between urinary GLY and renal tubular damage in non-occupationally exposed patients with kidney disease, with urinary GLY concentrations ranging from 1.40 to 3.12 ng/ml. Consistent with the findings of the above animal studies, we observed that urinary GLY was closely associated with the histological severity of tubular injury. Patients with moderate-to-severe tubular injury had higher urinary GLY levels than those with mild injury, and the risk of moderate-to-severe tubular injury increased markedly when urinary GLY levels exceeded 2.5 ng/ml. A recent study reported that GLY disrupts mitochondrial function and enhances oxidative stress, collectively contributing to tubulointerstitial damage [30]. In our study, we also examined the associations between urinary GLY levels and other renal histopathological features including renal interstitial edema, inflammatory cell infiltration, and interstitial fibrosis; however, no significant associations were observed (data not shown). This does not necessarily exclude a role for GLY in these processes, as tubular injury may represent an earlier or more sensitive manifestation of GLY-induced nephrotoxicity, whereas fibrotic changes may require longer exposure duration or higher cumulative doses to become evident. Table 3.Cytotoxic and genotoxic effects of GLY on kidney.ModelsEffectsHEK293 cells70 μg/L GLY increases levels of DNA damage, and 3,500 μg/L GLY for 24 h induced irreversible DNA double-strand breaks[35].Swiss Albino mice renal tissuesIn the GLY-treated group (50 mg/kg bw/day, intraperitoneally administration, 3 days), glutathione levels significantly decrease whereas malondialdehyde levels significantly increase, compared with the control group [37].Sprague-Dawley Rat renal tissuesExposed for 90 days to 50 mg/kg bw/day GLY by drinking water, the mRNA expression of DNA damage-related genes including Nr1d2, Clec2g, and Gadd45g is increased [36].Wistar rat renal medulla500 µM GLY at 37 °C decreased maximal uncoupled mitochondrial respiration in the medulla [30].Zebrafish kidneyZebrafish exposed to 90 μg/mL GLY up-regulates the havcr1 expression level, and cystic dilatation of the kidney [1].ICR mice kidneyGLY combined with hard water significantly upregulated the expression of the endoplasmic reticulum (ER) stress marker proteins Bip, ATF6, and PERK as well as the pyroptosis-related proteins including NLRP3 and caspase 1 in renal tissues [38].Sprague Dawley gestating female ratsTransient glyphosate exposure in pregnant rats led to the onset of kidney disease in their directly unexposed great-grand offspring (F3 generation), demonstrating the capacity of glyphosate to promote the transgenerational inheritance of pathology [39].Abbreviations: GLY, glyphosate. Cytotoxic and genotoxic effects of GLY on kidney. Abbreviations: GLY, glyphosate. Urinary β2-MG and NAG have been recognized as classic biomarkers of renal tubulointerstitial injury [31,32]; however, in our study, neither was associated with tubular injury score. In addition, urinary GLY levels were not significantly correlated with conventional biomarkers of kidney injury, including Cr, urea, eGFR, β2-MG and NAG. One possible explanation is that, in addition to tissue injury, the renal excretion of these urinary biomarkers may be influenced by individual characteristics and etiopathological factors [33]. Liu et al. reported a positive association between urinary GLY levels and tubular injury biomarkers (KIM-1 and NGAL) in children living near major vegetable-producing regions [10]. Interestingly, the present study demonstrated that elevated urinary GLY levels were significantly associated with an increased risk of moderate-to-severe renal tubular injury and further highlighted a nonlinear relationship between the two. Furthermore, the predictive performance of urinary GLY (AUC = 0.71) suggests that urinary GLY may serve as an effective and sensitive biomarker for identifying moderate-to-severe tubular injury. Further network toxicology analysis revealed potential GLY-related targets and pathways. GO and KEGG enrichment analyses (Figure 4) identified multiple biological processes, including DNA damage and cell apoptosis, oxidative stress, mitochondrial function, endoplasmic reticulum stress, and cell pyroptosis. These in silico predictions are supported by experimental evidence (Table 3). Our KEGG analysis identified the apoptosis and p53 signaling pathways, consistent with Mehtiyev et al. who reported GLY-induced upregulation of P53, BAX, CASP3, and CASP9 [34]. Exposure to GLY concentrations exceeding 70 μg/L resulted in elevated levels of DNA damage in HEK293 cells, with a 24-h exposure to 3,500 μg/L of GLY causing irreversible DNA strand breaks [35]. Similarly, in Sprague-Dawley rats, a 90-day exposure to 50 mg/kg body weight per day of GLY via drinking water led to increased mRNA expression of DNA damage-related genes in renal tissues, including Nr1d2, Clec2g, and Gadd45g [36]. Predictions related to oxidative stress and mitochondrial dysfunction were substantiated by glutathione depletion and increased malondialdehyde levels in mice [37], as well as reduced mitochondrial respiration in the rat renal medulla [30]. The pathways involving endoplasmic reticulum stress and cell pyroptosis were validated through the upregulation of Bip, ATF6, PERK, NLRP3, and caspase 1 in ICR mice [38]. In addition, the reported transgenerational effects on renal function in rats [39] suggest the involvement of epigenetic mechanisms beyond acute toxicity, while the enrichment of the ‘female gonad development’ pathway is consistent with the known reproductive effects of GLY [40,41]. Collectively, the concordance between our network toxicology predictions and independent experimental evidence supports the biological plausibility of GLY-induced nephrotoxicity through interconnected molecular pathways, providing a mechanistic framework for understanding renal toxicity associated with low-dose environmental exposure. In conclusion, elevated urinary GLY levels were associated with an increased risk of moderate-to-severe renal tubular injury in patients with kidney disease without occupational exposure. GLY exposure may represent a potential risk factor for tubular injury. These findings, together with mechanistic insights from toxicological analyses, support the potential nephrotoxicity of low-dose glyphosate exposure in a clinical cohort and add to the limited epidemiological evidence linking environmental glyphosate exposure to renal pathological injury. However, several limitations should be acknowledged. First, urinary GLY is an exposure biomarker, and its association with tubular injury does not imply causality. In addition, owing to study constraints, a healthy control group with concurrent urinary GLY measurements was not included, and some renal-injury biomarkers, such as KIM-1 and NGAL, were not assessed. Future case-control studies including matched healthy controls and additional novel biomarkers are warranted to further validate our findings. Second, although patients with occupational exposure, such as farmers and industrial workers, were excluded, residual confounding could not be completely eliminated. Potential confounding factors, including dietary habits, drinking water source, residential proximity to agricultural areas, household pesticide use, and environmental contamination, were not comprehensively assessed. Future studies should incorporate a more detailed evaluation of these factors. Third, urinary GLY was measured only once at the time of biopsy, primarily reflecting recent exposure rather than long-term accumulation. Repeated measurements over time would provide a more accurate assessment of chronic exposure and its relationship with renal pathology. Fourth, although tubular injury scoring was performed independently by two blinded pathologists, formal interobserver agreement was not evaluated. This may have introduced subjectivity into the histopathological assessment, and future studies should include validated reliability analyses to improve reproducibility. Finally, this was a retrospective, single-center study with a relatively small sample size, which may limit the generalizability of the findings. Larger prospective multicenter studies with longitudinal sampling are needed to further validate these results.